Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M800902200 on February 4, 2008

J. Biol. Chem., Vol. 283, Issue 16, 10461-10469, April 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/16/10461    most recent
M800902200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, R.
Right arrow Articles by Simonson, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, R.
Right arrow Articles by Simonson, M. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

AMP-activated Protein Kinase Inhibits Transforming Growth Factor-β-induced Smad3-dependent Transcription and Myofibroblast Transdifferentiation*

Rangnath Mishra{ddagger}, Barbara L. Cool§, Keith R. Laderoute, Marc Foretz||**, Benoit Viollet||**, and Michael S. Simonson{ddagger}1

From the {ddagger}Division of Nephrology and Hypertension, Department of Medicine, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland Ohio 44106, the §Department of Metabolic Disease Research, Abbott Laboratories, Abbott Park, Illinois 60064, SRI International, Menlo Park, California 94025, ||Institut Cochin, Universite Paris Descartes, CNRS (UMR 8104), 75014 Paris, France, and **INSERM, U567, 75014 Paris, France

In wound healing, myofibroblast transdifferentiation (MFT) is a metaplastic change in phenotype producing profibrotic effector cells that secrete and remodel the extracellular matrix. Unlike pathways that induce MFT, the molecular mechanisms that negatively regulate MFT are poorly understood. Here, we report that AMP-activated protein kinase (AMPK) blocks MFT in response to transforming growth factor-β (TGFβ). Pharmacological activation of AMPK inhibited TGFβ-induced secretion of extracellular matrix proteins collagen types I and IV and fibronectin. AMPK activation also prevented induction of the myofibroblast phenotype markers {alpha}-smooth muscle actin and the ED-A fibronectin splice variant. AMPK activators did not prevent MFT in cells transduced with an adenovirus expressing dominant negative, kinase-dead AMPK{alpha}2. Moreover, AMPK activators did not inhibit MFT induction in AMPK{alpha}1,2–/– fibroblasts, demonstrating a requirement for AMPK{alpha} expression. Adenoviral transduction of constitutively active AMPK{alpha}2 was sufficient to prevent TGFβ-induced collagen I, {alpha}-smooth muscle actin, and ED-A fibronectin. AMPK did not reduce TGFβ-stimulated Smad3 COOH-terminal phosphorylation and nuclear translocation, which are necessary for MFT. However, AMPK activation inhibited TGFβ-induced transcription driven by Smad3-binding cis-elements. Consistent with a role for AMPK in transcriptional regulation, nuclear translocation of AMPK{alpha}2 correlated with the appearance of active AMPK{alpha} in the nucleus. Collectively, these results demonstrate that AMPK inhibits TGFβ-induced transcription downstream of Smad3 COOH-terminal phosphorylation and nuclear translocation. Furthermore, activation of AMPK is sufficient to negatively regulate MFT in vitro.


Received for publication, February 4, 2008

* This work was supported by grants from the Rosenberg Foundation of the Centers for Dialysis Care (Cleveland, OH) and from the EXGENESIS Integrated Project (Grant LSHM-CT-2004-005272) funded by the European Commission (to B. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Medicine, Division of Nephrology, Biomedical Research Bldg., Rm. 427, Case Western Reserve University, 2109 Adelbert Rd., Cleveland, OH 44106. Tel.: 216-368-1251; Fax: 216-368-1249; E-mail: mss5{at}po.cwru.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
D. Xing and J. A. Bonanno
Effect of cAMP on TGF{beta}1-Induced Corneal Keratocyte-Myofibroblast Transformation
Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 626 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Vaahtomeri, E. Ventela, K. Laajanen, P. Katajisto, P.-J. Wipff, B. Hinz, T. Vallenius, M. Tiainen, and T. P. Makela
Lkb1 is required for TGF{beta}-mediated myofibroblast differentiation
J. Cell Sci., November 1, 2008; 121(21): 3531 - 3540.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement